McMahon

Memphis-based VC firm Ridgeline Launches Oversubscribed $52m Fund I

Retrieved on: 
Tuesday, October 4, 2022

Ridgeline , a Memphis, Tennessee-based early-stage venture capital firm led by founding partners Ryan Clinton, Ben Walker, and Andrew McMahon, closed its inaugural $52m Fund.

Key Points: 
  • Ridgeline , a Memphis, Tennessee-based early-stage venture capital firm led by founding partners Ryan Clinton, Ben Walker, and Andrew McMahon, closed its inaugural $52m Fund.
  • These strategic corporate LPs, through investing with Ridgeline, intend to drive innovation in their organizations by conducting meaningful pilots and proofs of concept with the firms portfolio.
  • Ridgeline invested in Wallaroo in January 2020, helping the company grow its revenue across multiple government and commercial customers.
  • The firm has made 17 investments in Fund I to date and expects to invest in up to 30 companies throughout the life of the fund.

Micron Announces Historic Investment of up to $100 Billion to Build Megafab in Central New York

Retrieved on: 
Tuesday, October 4, 2022

The new megafab will increase domestic supply of leading-edge memory and create nearly 50,000 New York jobs, including approximately 9,000 high paying Micron jobs.

Key Points: 
  • The new megafab will increase domestic supply of leading-edge memory and create nearly 50,000 New York jobs, including approximately 9,000 high paying Micron jobs.
  • Microns investment in Onondaga County, New York, will complement the companys previously announced high-volume manufacturing fab in Boise, Idaho.
  • Micron will leverage the diverse, highly educated and skilled talent in New York as we look to build our workforce in the Empire State, said Micron President and CEO Sanjay Mehrotra.
  • Micron, the Micron logo, and all other Micron trademarks are the property of Micron Technology, Inc. All other trademarks are the property of their respective owners.

WORLD WRESTLING ENTERTAINMENT, INC. (NYSE: WWE) INVESTIGATION ALERT: Bernstein Liebhard is Investigating World Wrestling Entertainment, Inc.

Retrieved on: 
Tuesday, September 27, 2022

NEW YORK, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, is investigating whether members of the Board of Directors (the “Board”) of World Wrestling Entertainment, Inc. (“WWE” or the “Company”) (NYSE: WWE) breached their fiduciary duties in connection with alleged sexual misconduct by WWE’s former Chairman and Chief Executive Officer Vincent McMahon. McMahon stepped down temporarily as CEO and Chairman of WWE in mid-June during an investigation into the alleged misconduct. The Wall Street Journal has reported that McMahon agreed to pay more than $12 million over the past 16 years to suppress allegations of sexual misconduct and infidelity. McMahon resigned from the Company on July 22, 2022 and is under investigation by the Board.

Key Points: 
  • Shareholder Investigation or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • McMahon stepped down temporarily as CEO and Chairman of WWE in mid-June during an investigation into the alleged misconduct.
  • If you hold WWE common stock and would like to discuss your legal rights and options please visit World Wrestling Entertainment, Inc.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Law Firm of Corsiglia, McMahon & Allard Announces that West Valley-Mission Community College District Settles for $7.6 Million with Disabled Rape Victim

Retrieved on: 
Thursday, September 22, 2022

The West Valley-Mission Community College District will pay a disabled rape victim $7.6 million as a result of a lawsuit filed by the law firm of Corsiglia, McMahon & Allard.

Key Points: 
  • The West Valley-Mission Community College District will pay a disabled rape victim $7.6 million as a result of a lawsuit filed by the law firm of Corsiglia, McMahon & Allard.
  • The lawsuit filed in 2020 alleged that district officials failed to protect a now 26-year-old developmentally disabled woman from a known sexual predator.
  • The alleged predator, Raymond Ruiz, was an instructional aide in the Program for Students with Developmental Disabilities that holds classes at Mission College in Santa Clara.
  • In our investigation, we discovered that Raymond Ruiz had sexually assaulted one student and physically assaulted another, attorney Mark Boskovich said.

Bragar Eagel & Squire, P.C. Is Investigating Olo, Cognyte, Vintage Wine, and the WWE and Encourages Investors to Contact the Firm

Retrieved on: 
Saturday, September 17, 2022

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • Olo also stated that [t]he partnership allows Subways network of more than 20,000 U.S. restaurants to more seamlessly handle digital orders from third-party marketplaces.
  • Then, on August 11, 2022, Olo issued a press release announcing its second quarter 2022 financial results.
  • For more information on the WWE investigation go to: https://bespc.com/cases/WWE
    About Bragar Eagel & Squire, P.C.

WORLD WRESTLING ENTERTAINMENT, INC. (NYSE: WWE) INVESTIGATION ALERT: Bernstein Liebhard is Investigating World Wrestling Entertainment, Inc.

Retrieved on: 
Tuesday, September 13, 2022

NEW YORK, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, is investigating whether members of the Board of Directors (the “Board”) of World Wrestling Entertainment, Inc. (“WWE” or the “Company”) (NYSE: WWE) breached their fiduciary duties in connection with alleged sexual misconduct by WWE’s former Chairman and Chief Executive Officer Vincent McMahon. McMahon stepped down temporarily as CEO and Chairman of WWE in mid-June during an investigation into the alleged misconduct. The Wall Street Journal has reported that McMahon agreed to pay more than $12 million over the past 16 years to suppress allegations of sexual misconduct and infidelity. McMahon resigned from the Company on July 22, 2022 and is under investigation by the Board.

Key Points: 
  • Shareholder Investigation or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • McMahon stepped down temporarily as CEO and Chairman of WWE in mid-June during an investigation into the alleged misconduct.
  • If you hold WWE common stock and would like to discuss your legal rights and options please visit World Wrestling Entertainment, Inc.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Bragar Eagel & Squire, P.C. Is Investigating EyePoint, Olo, Cognyte, and the WWE and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, September 12, 2022

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On August 30, 2022, after market hours, EyePoint disclosed that it had received a subpoena from the U.S.
  • On this news, EyePoint stock fell $0.21 per share, or 2%, to close at $10.00 per share on August 31, 2022.
  • For more information on the WWE investigation go to: https://bespc.com/cases/WWE
    About Bragar Eagel & Squire, P.C.

STORM Therapeutics Appoints Dr. Jerry McMahon as Chief Executive Officer

Retrieved on: 
Wednesday, September 7, 2022

CAMBRIDGE, England, Sept. 7, 2022 /PRNewswire/ -- STORM Therapeutics Ltd. (STORM), the biotechnology company discovering and developing novel small molecule therapies targeting RNA modification enzymes for oncology and other diseases, today announced the appointment of Dr. Gerald (Jerry) McMahon as President and Chief Executive Officer and Board Director.

Key Points: 
  • CAMBRIDGE, England, Sept. 7, 2022 /PRNewswire/ -- STORM Therapeutics Ltd. (STORM), the biotechnology company discovering and developing novel small molecule therapies targeting RNA modification enzymes for oncology and other diseases, today announced the appointment of Dr. Gerald (Jerry) McMahon as President and Chief Executive Officer and Board Director.
  • Dr. Jerry McMahon added:"STORM is well positioned to fulfil its ambition of becoming the global leader in the field of RME.
  • Dr. McMahon was President and CEO of NASDAQ listed Harpoon Therapeutics, building the Company from early stage through to IPO, follow-on financings, and development collaborations.
  • STORM Therapeutics (STORM) is a biotechnology company creating novel therapies that inhibit RNA modifying enzymes (RME) for use in oncology and other diseases.

STORM Therapeutics Appoints Dr. Jerry McMahon as Chief Executive Officer

Retrieved on: 
Wednesday, September 7, 2022

CAMBRIDGE, England, Sept. 7, 2022 /PRNewswire/ -- STORM Therapeutics Ltd. (STORM), the biotechnology company discovering and developing novel small molecule therapies targeting RNA modification enzymes for oncology and other diseases, today announced the appointment of Dr. Gerald (Jerry) McMahon as President and Chief Executive Officer and Board Director.

Key Points: 
  • CAMBRIDGE, England, Sept. 7, 2022 /PRNewswire/ -- STORM Therapeutics Ltd. (STORM), the biotechnology company discovering and developing novel small molecule therapies targeting RNA modification enzymes for oncology and other diseases, today announced the appointment of Dr. Gerald (Jerry) McMahon as President and Chief Executive Officer and Board Director.
  • Dr. Jerry McMahon added:"STORM is well positioned to fulfil its ambition of becoming the global leader in the field of RME.
  • Dr. McMahon was President and CEO of NASDAQ listed Harpoon Therapeutics, building the Company from early stage through to IPO, follow-on financings, and development collaborations.
  • STORM Therapeutics (STORM) is a biotechnology company creating novel therapies that inhibit RNA modifying enzymes (RME) for use in oncology and other diseases.

Bragar Eagel & Squire, P.C. Is Investigating the WWE, F45, and Avaya and Encourages Investors to Contact the Firm

Retrieved on: 
Wednesday, September 7, 2022

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • On this news, Avaya stock fell $0.20 per share, or 23%, to close at $0.67 per share on August 10, 2022.
  • For more information on the Avaya investigation go to: https://bespc.com/cases/AVYA
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.